Results 11 to 20 of about 65,795 (216)

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr-mutated lung cancer. [PDF]

open access: yesMol Oncol
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Nishimura J   +19 more
europepmc   +2 more sources

Amelanotic Signet Ring Cell Melanoma Presenting as Breast Lump- A Diagnostic Conundrum [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2017
Amelanotic signet ring cell melanoma is one of the rare variants of malignant melanoma. Here we are presenting a case of a 58- year-old female with chief complaints of swelling in the left sternal region/breast, and right cervical region.
Prasath Sathiah   +4 more
doaj   +1 more source

Solitary Intramammary Plexiform Schwannoma Mimicking Phyllodes Tumour on Cytology [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2017
Plexiform schwannoma is a rare subtype of schwannoma with no case reported in the breast to the best of our knowledge. We report a case of intramammary plexiform schwannoma in a 20-year-old female which was diagnosed as Phyllodes tumour on cytology ...
Shveta, Kiran Agarwal, Ankita Sharma
doaj   +1 more source

Eye retinal changes under the influence of chromium ions

open access: yesJournal of Ophthalmology, 2018
Introduction. Relationships between human eyes and metal ions take multiple forms. Neurotoxicity manifests as peripheral neuropathy, sensorineural hearing loss; ocular toxicity is presented as visual impairment.
Y. V Kuzenko   +2 more
doaj   +1 more source

Langerhans Cell Histiocytosis with the Synchronous Invasion of Stomach and Colon in an Adult Patient: A Case Report

open access: yesThe Korean Journal of Gastroenterology, 2022
Langerhans cell histiocytosis (LCH) is reported less frequently in adults than in children. The most common site of involvement in adults is the bone, accounting for 30-50% of cases. The gastrointestinal tract is very rare, accounting for approximately 2%
Seong Je Kim   +8 more
doaj   +1 more source

AGEs and RAGE: metabolic and molecular signatures of the glycation-inflammation axis in malignant or metastatic cancers

open access: yesExploration of Targeted Anti-tumor Therapy, 2023
From attributing mutations to cancers with the advent of cutting-edge genetic technology in recent decades, to re-searching the age-old theory of intrinsic metabolic shift of cancers (Warburg’s glycolysis), the quest for a precise panacea for mainly the ...
Gowri Palanissami, Solomon F.D. Paul
doaj   +1 more source

Cutaneous nodular fasciitis in the dog. Morphological and immunohistochemical study

open access: yesBrazilian Journal of Veterinary Pathology, 2009
Nodular fasciitis is a benign soft tissue lesion commonly diagnosed in human beings, but with rare description in dogs and cats. A female, spayed, 7.5 years old, otherwise healthy Labrador was examined because of a nodular growth of rapid development in ...
Lissandro G. Conceição   +6 more
doaj   +1 more source

Oral Granular Cell Tumor: A Case Report with Emphasis on Pseudoepitheliomatous Hyperplasia in Oral Lesions [PDF]

open access: yesJournal of Dentistry
A granular cell tumor (GCT) is an unusual benign mesenchymal neoplasm with Schwann cells origin. The most common site is the dorsum of the tongue. It has a striking tendency to occur in females and is more frequent in adult patients.
Saede Atarbashi Moghadam   +2 more
doaj   +1 more source

S100 as Serum Tumor Marker in Advanced Uveal Melanoma

open access: yesBiomolecules, 2023
S100 protein is routinely used as a serum tumor marker in advanced cutaneous melanoma. However, there is scarce and inconclusive evidence on its value in monitoring disease progression of uveal melanoma.
Martin Salzmann   +2 more
doaj   +1 more source

S100 Calcium Binding Protein Family Members Associate With Poor Patient Outcome and Response to Proteasome Inhibition in Multiple Myeloma

open access: yesFrontiers in Cell and Developmental Biology, 2021
Despite several new therapeutic options, multiple myeloma (MM) patients experience multiple relapses and inevitably become refractory to treatment. Insights into drug resistance mechanisms may lead to the development of novel treatment strategies.
Minxia Liu   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy